Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance
The FOXO3a and FOXM1 forkhead transcription factors are key players in cancer initiation, progression, and drug resistance. Recent research shows that FOXM1 is a direct transcriptional target of FOXO3a, a vital downstream effector of the PI3K-AKT-FOXO signaling cascade. In addition, FOXM1 and FOXO3a...
Main Authors: | , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Sun Yat-sen University Cancer Center
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845605/ |
id |
pubmed-3845605 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-38456052013-12-11 Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance Gomes, Ana R. Zhao, Fung Lam, Eric W.F. Review The FOXO3a and FOXM1 forkhead transcription factors are key players in cancer initiation, progression, and drug resistance. Recent research shows that FOXM1 is a direct transcriptional target of FOXO3a, a vital downstream effector of the PI3K-AKT-FOXO signaling cascade. In addition, FOXM1 and FOXO3a also antagonize each other's activity by competitively binding to the same target genes, which are involved in chemotherapeutic drug sensitivity and resistance. Understanding the role and regulation of the FOXO-FOXM1 axis will provide insight into chemotherapeutic drug action and resistance in patients, and help to identify novel therapeutic approaches as well as diagnostic and predictive biomarkers. Sun Yat-sen University Cancer Center 2013-07 /pmc/articles/PMC3845605/ /pubmed/23706767 http://dx.doi.org/10.5732/cjc.012.10277 Text en Chinese Journal of Cancer http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Gomes, Ana R. Zhao, Fung Lam, Eric W.F. |
spellingShingle |
Gomes, Ana R. Zhao, Fung Lam, Eric W.F. Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance |
author_facet |
Gomes, Ana R. Zhao, Fung Lam, Eric W.F. |
author_sort |
Gomes, Ana R. |
title |
Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance |
title_short |
Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance |
title_full |
Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance |
title_fullStr |
Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance |
title_full_unstemmed |
Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance |
title_sort |
role and regulation of the forkhead transcription factors foxo3a and foxm1 in carcinogenesis and drug resistance |
description |
The FOXO3a and FOXM1 forkhead transcription factors are key players in cancer initiation, progression, and drug resistance. Recent research shows that FOXM1 is a direct transcriptional target of FOXO3a, a vital downstream effector of the PI3K-AKT-FOXO signaling cascade. In addition, FOXM1 and FOXO3a also antagonize each other's activity by competitively binding to the same target genes, which are involved in chemotherapeutic drug sensitivity and resistance. Understanding the role and regulation of the FOXO-FOXM1 axis will provide insight into chemotherapeutic drug action and resistance in patients, and help to identify novel therapeutic approaches as well as diagnostic and predictive biomarkers. |
publisher |
Sun Yat-sen University Cancer Center |
publishDate |
2013 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845605/ |
_version_ |
1612032341335605248 |